Identification of particles in a pharmaceutical solution
Your needs: identify the origin and nature of particles in your pharmaceutical solutions
In order to be marketed, new drugs undergo numerous clinical tests throughout their development. Once the drug is approved for marketing, quality controls are carried out throughout its life cycle and production to verify its compliance.
The smallest particle or the slightest variation in the drug can lead manufacturers to withdraw the pharmaceutical product from the market. This is why many protocols and analytical means are developed to guarantee the conformity of the product according to dedicated standards.
Have you identified an unknown particle in your pharmaceutical solution during your production process and would you like to analyze it? Call on FILAB!
Our solutions: supporting drug manufacturers in the identification of particles in their pharmaceutical solutions
FILAB laboratory offers pharmaceutical companies technical skills and state-of-the-art analytical equipment to meet their particle identification needs.
In order to meet these requirements with precision and reliability, FILAB offers a tailor-made support for the identification of your pharmaceutical solutions:
- Identification of particles in your pharmaceutical solutions by scanning electron microscopy (SEM)
- Analysis and characterization of the nature of the particles by infrared microscopy (FTIR)
- Analysis and identification of particles in your pharmaceutical solutions by ICP-MS, ICP-AES
For more information about your particle identification needs (24/48h emergency package), please consult our expert opinion or contact us: contact@filab.fr – tel: 03.80.52.32.05 or ask for a quote online here.
